IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 81 - 100 of 1271 stories.
January 6, 2015
FDA issues warning letter to API plant in China FDA issued a warning letter on 19 December to the active pharmaceutical ingredient (API) and finished pharmaceutical manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-6-January-2015_66577.html
January 5, 2015
The number of new drugs approved by FDA last year rose to 41 from 27 in 2013, the highest number for 18 years. The 2014 approval list included 15 drugs for so-called orphan...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-new-drug-approvals-rise-to-18-year-high_66541.html
January 5, 2015
Novartis has announced it completed, on 1 January, divesting its animal health division to Eli Lilly for approximately $5.40 billion. The deal is part of a comprehensive set of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novartis-completes-divestment-of-animal-health-business-to-Eli-Lilly-for-$5-4-billion_66540.html
January 5, 2015
SRF (Gurgaon), a leading Indian manufacturer of hydrofluorocarbon (HFC) refrigerants, has acquired the global HFC-134a pharmaceutical propellant gases business of DuPont for $20...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Indian-firm-acquires-DuPonts-Dymel-pharma-grade-HFC-134a-business_66538.html
December 31, 2014
FDA issued a warning letter on 19 December to the active pharmaceutical ingredient (API) and finished pharmaceutical manufacturing facilities of Novacyl Wuxi Pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-issues-warning-letter-to-API-plant-in-China_66511.html
December 30, 2014
Merck KGaA receives US antitrust clearance for acquisition of Sigma-Aldrich for $17 billion Merck KGaA (Darmstadt, Germany) and life science company Sigma-Aldrich (St. Louis) announced...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-30-December-2014_66494.html
December 24, 2014
Reckitt Benckiser (RB), a leading global consumer health and hygiene company, said that it has completed the demerger of its specialty pharmaceuticals business Indivior. Indivior...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Reckitt-Benckiser-completes-pharma-demerger_66446.html
December 23, 2014
Indian pharma major Cipla (Mumbai) said today that its Cipla Medpro subsidiary, the third-largest pharma company in South Africa, has been awarded a 2.00-billion rand ($172.7 million)...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Indian-pharma-firm-wins-South-African-ARV-tender_66422.html
December 23, 2014
Cambridge Major to expand Germantown API facility Cambridge Major Laboratories (CML; Germantown, WI), a producer of pharmaceutical intermediates and active pharmaceutical ingredients...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-23-December-2014_66414.html
December 19, 2014
Shareholders of GlaxoSmithKline (GSK) on Thursday approved by an overwhelming majoring a planned deal with Novartis, which sets the two pharma groups to trade more than $20.0 billion...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/GSK-shareholders-approve-$20-billion-asset-deal-with-Novartis_66362.html
December 19, 2014
Bayer HealthCare and Cardinal Health (Dublin, OH) have signed a 15-year agreement for the contract manufacturing of Bayer’s Xofigo (radium Ra 223 dichloride) drug. As part of the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Bayer-to-outsource-production-of-major-drug-to-Cardinal-Health_66360.html
December 17, 2014
UCB, Advent International and Avista Capital Partners said on Tuesday that they have agreed to terminate their agreement, announced on 7 November 2014, for Advent and Avista to acquire...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/UCB-terminates-agreement-to-sell-generic-drugs-unit-to-private-equity-groups_66235.html
December 12, 2014
Abbott has announced the completion of the purchase of Veropharm, a leading Russian pharmaceuticals manufacturer. Abbott announced in June that it acquired control of Veropharm for...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Abbott-completes-acquisition-of-Russian-pharma-firm_66144.html
December 11, 2014
Pharmaceuticals producer Cipla (Mumbai) has announced the sale its stake in Jiangsu Cdymax Pharmaceuticals for $18.5 million as part of a realignment of its global business. Cipla says...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cipla-sells-its-stake-in-Chinese-pharma-company_66077.html
December 9, 2014
Johnson Matthey acquires pharmaceutical ingredients facility in UK Johnson Matthey says that it has completed the acquisition of a pharmaceutical manufacturing facility at Annan, UK...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-9-December-2014_65988.html
December 8, 2014
Aurobindo Pharma (Hyderabad, India) said on Friday that it had completed acquiring assets of nutritional supplement maker Natrol and other affiliate entities through a wholly owned US...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Aurobindo-completes-acquisition-of-US-nutraceuticals-firm-Natrol_65943.html
December 8, 2014
Merck announced today that it has reached an agreement to acquire Cubist Pharmaceuticals (Lexington, MA) for $102/share in cash, which represents a 35% premium to Cubist’s...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-to-acquire-Cubist-Pharmaceuticals-for-$8-40-billion_65959.html
December 8, 2014
Sun Pharmaceutical Industries (Mumbai) and Ranbaxy Laboratories (Gurgaon, India) say that the Competition Commission of India (CCI; New Delhi) on 5 December approved Sun...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Competition-Commission-of-India-okays-Sun-Pharmas-acquisition-of-Ranbaxy_65964.html
December 8, 2014
Sanofi’s animal health subsidiary Merial is acquiring the Merck manufacturing facility at Barceloneta, Puerto Rico. The transaction is subject to approval by FTC. If approved...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sanofi-acquires-Mercks-animal-health-facility-in-Puerto-Rico_65950.html
December 5, 2014
Arbor Pharmaceuticals (Atlanta), a specialty pharmaceutical company, said on Thursday that private equity firm KKR is acquiring a “significant minority stake” in the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/KKR-acquires-stake-in-US-company-Arbor-Pharmaceuticals_65914.html
Pages: « Previous  1 2 3 4 [5] 6 7 8 9 10 11 12 13 14 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa